An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Online
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Worries
Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.
Several professionals said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking fines, legal action or prison.
Platform Response and Content Removal
According to the social media company, the platform has taken down problematic material and banned associated hashtags and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for preparing or administering at home.
After minutes of joining one community, a vendor posted contact information, where the majority of transactions take place. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about weight, health issues or previous experience.
Product Details and Pricing
Within these groups, messages show black plastic parcels with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has previously seen patients harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject users to possibly significant medical dangers”.
